Day: April 26, 2021

Avenir LNG announces the first bunkering of the Avenir Accolade by its sister ship the Avenir Advantage

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Avenir LNG (NOTC: AVENIR) today announced that it has successfully completed the bunkering of the Avenir Accolade by its sister ship the Avenir Accolade in Pasir Gudang, Pengerang, Malaysia on 26 April 2021. Both ships built by Keppel Offshore & Marine’s Nantong Shipyard are 7,500 cbm, dual purpose, LNG supply and bunkering vessels (LBV). The Avenir Accolade undertook the operation whilst passing through Malaysia on its maiden voyage to deliver the commissioning cargo to Avenir’s HIGAS LNG terminal in Sardinia. Peter Mackey, CEO Avenir LNG Limited, commented: “We’re thrilled to see the Avenir Advantage alongside the Avenir Accolade, the first time they are back together since leaving the shipyard in Nantong. We look forward to welcoming the Avenir Accolade to our HIGAS terminal in Sardinia in a few weeks’ time with the commissioning...

Dyadic International organise une discussion informelle sur « Le potentiel de la technologie transformatrice des protéines à cellules C1 de Dyadic pour aider à relever les défis mondiaux en matière de santé »

Written by Customer Service on April 26, 2021. Posted in Public Companies.

La discussion informelle aura lieu le mardi 4 mai à 10 h (heure de l’Est) La discussion informelle aura lieu le mardi 4 mai à 10 h (heure de l'Est)

Dyadic International veranstaltet Kamingespräch mit dem Titel „The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health Challenges“

Written by Customer Service on April 26, 2021. Posted in Public Companies.

JUPITER, Fla., April 26, 2021 (GLOBE NEWSWIRE) — Dyadic International, Inc. („Dyadic“, „wir“, „uns“, „unser“ oder das „Unternehmen“) (NASDAQ:DYAI), ein globales Biotechnologieunternehmen, das sich auf die Entwicklung und den Einsatz seiner proprietären C1-Zellen-Protein-Produktionsplattform konzentriert, mit der die Entwicklung von Impfstoffen, Therapeutika und anderen proteinbasierten Produkten optimiert werden soll, hat heute bekanntgegeben, dass es am Dienstag, den 4. Mai 2021, um 16:00 Uhr CEST ein Kamingespräch organisiert. Hauptthema des Kamingesprächs wird das Potenzial der transformativen C1-Proteintechnologie von Dyadic zur Bewältigung globaler gesundheitlicher Herausforderungen sein. Die moderierte Diskussion umfasst die folgenden Key Opinion Leaders (KOLs):Alain Townsend, Ph.D. – Weatherall Institute – Oxford University Albert...

Dyadic International主办炉边谈话以讨论“变革型Dyadic C1蛋白质技术在帮助应对全球健康挑战方面的潜力”

Written by Customer Service on April 26, 2021. Posted in Public Companies.

炉边谈话将于5月4日（星期二）东部时间上午10点举行炉边谈话将于5月4日（星期二）东部时间上午10点举行

Dyadic International, ‘변형 Dyadic C1 단백질 기술이 글로벌 보건 과제를 해결에 기여할 잠재력’ 주제로 파이어사이드 챗 개최

Written by Customer Service on April 26, 2021. Posted in Public Companies.

미국 플로리다주 주피터, April 26, 2021 (GLOBE NEWSWIRE) — 글로벌 바이오테크 기업인 Dyadic International, Inc. (NASDAQ: DYAI)은 2021년 5월 4일 오전 10시(미국동부시간) 파이어사이드 챗(fireside chat) 행사를 실시한다고 밝혔다. Dyadic International은 자체 개발한 C1-cell 단백질 생산 플랫폼의 적용, 공급을 통해 백신과 치료제 및 기타 단백질 기반 제품 개발을 촉진하는 데 중점을 두고 있다. 파이어사이드 챗은 변형 Dyadic C1 단백질 기술이 글로벌 보건 과제를 해결하는 데 도움을 줄 잠재력을 다룰 예정이다. 사회자를 두고 진행되는 이번 좌담에는 핵심 오피니언 리더(KOL)들이 참여한다:Alain Townsend, Ph.D. – Weatherall Institute – 옥스퍼드대 Albert Osterhaus, P.V.M, Ph.D. – 에라스무스대병원 Cecil Nick – Parexel (임상 및 규제 지원 담당) Joris Vandeputte – 생물의약품 표준화 국제연합좌담 주제는 다음과 같다:C1 플랫폼의 규제 고려 사항과 장점 다른 생산 플랫폼과 관련해 슈말렌베르그 바이러스와 리프트밸리열 바이러스용 고가치 항원의 성공적인 생산에 대한 사례 연구 Dyadic의 SARS-CoV-2 수용체 결합영역 백신 후보인 DYAI-100의 개발 진행, 이미 알려진 변이 및 신종 변이 발현을 위한 C1 세포주 급속 엔지니어링 등 SARS-CoV-2 변이에 대응하기 위한 Dyadic의 노력 코로나19 다가백신, 그리고 대부분의...

Dyadic International Mengadakan Sembang Santai Tentang “Potensi Teknologi Protein C1 Dyadic yang Transformatif dalam Membantu untuk Menangani Cabaran Kesihatan Global”

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Sembang Santai Diadakan pada Selasa, 4hb Mei @ 10 pagi Waktu Timur Sembang Santai Diadakan pada Selasa, 4hb Mei @ 10 pagi Waktu Timur

Konsolidator signs the first customer in Belgium

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Press release no 5-2021 Søborg, April 26, 2021 Konsolidator signs the first customer in Belgium Konsolidator has signed its first customer in Belgium. This means that Konsolidator’s software is now being used by customers in 15 different countries across Europe, Africa, Asia, the Middle East, and North America.    The Belgium customer is a result of Konsolidator’s go-to-market plan that uses online marketing to drive interest and traffic to Konsolidator and that way allowing Konsolidator to market the software in new countries without a local presence. “We are excited to engage the first customer in Belgium. We believe that Konsolidator will be well received in the Benelux and eventually we will make a greater effort to assist the finance professionals in the Benelux to become better through simplicity”, says CEO Claus Finderup...

Eik fasteignafélag hf.: Rafrænn aðalfundur

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Hluthafar eru minntir á að aðalfundur Eikar fasteignafélags hf. sem fram fer kl. 16:00 í dag verður alfarið rafrænn. Hluthafar sem ekki hafa skráð sig en hyggjast taka þátt í fundinum eru beðnir að senda tölvupóst á stjornun@eik.is fyrir kl. 15:00 í dag með nafni, kennitölu, farsímanúmeri og netfangi auk afrits af persónuskilríkjum og umboði (ef við á).

Costamare Inc. Announces the Acquisition of the York Capital Majority Interest in Five 11,000 TEU Containerships with Long-Term Charters

Written by Customer Service on April 26, 2021. Posted in Mergers And Acquisitions.

MONACO, April 26, 2021 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE) announced today the acquisition of York Capital’s 60% equity interest, on average, in five 11,000 TEU containerships, four of which were built in 2017 and one of which was built in 2016. The acquisition brings the Company’s ownership interest in these five vessels to 100%.

Human Insulin Market Size 2021 | Is Anticipated to Reach USD 27.71 Billion and Exhibit a CAGR of 3.4% by 2026

Written by Customer Service on April 26, 2021. Posted in Mergers And Acquisitions.

Pune, India, April 26, 2021 (GLOBE NEWSWIRE) — The global human insulin market size is anticipated to reach USD 27.71 billion by 2026. International Diabetes Federation (IDF) reported that around 425 million people across the world suffer from diabetes. This shows that the rising prevalence of diabetes is propelling growth in the market. Fortune Business Insights in a new report, predicts the market to exhibit a CAGR of 3.4% during the forecast period. In 2018, the market value stood at USD 21.26 billion in 2018. The adoption of delivery devices primarily for insulin administration is increasing, thus driving the market. Some of the other key players operating in the market are:Novo Nordisk A/S Eli Lilly and Company Boston Scientific Corporation Sanofi Boehringer Ingelheim International GmbH Biocon Tonghua Dongbao Pharmaceutical Julphar Wockhard Other...

Day: April 26, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals